I work in the HemOnc specialty and dealing with constant questions regarding the new modifers for 08, such as the Q0 and Q1 modifiers for clinical trials, and the E-modifiers for ESA and Hematocrit. Does anyone have any info on these modifiers, their use for 08, payer specific info, etc. Thanks.
Chisa Shoemake
Kansas City Cancer Center
Chisa Shoemake
Kansas City Cancer Center